Presented by
Management Forum

US Patent Practice

What all European patent attorneys need to know - an intensive and highly interactive two-day seminar including discussions on US patent law and strategies and tactics for patent prosecution at the US Patent Office

1-2 Dec 2021 + 3 more dates

Enrol now

  • Format: Live online, Classroom
  • CPD: 12 hours for your records
  • Certificate of completion

Course overview

Key topics covered:

  • Legal framework
  • Claim construction
  • US patent prosecution practice and procedure
  • The written description, enablement and best mode requirements
  • Definiteness
  • Statutory subject matter
  • Novelty and prior art
  • Obviousness
  • Provisional and continuing applications
  • Restriction practice and obviousness
    • Type double patenting
  • USPTO programs
  • Patent Law Treaty implementation
  • Duty of candor
  • Infringement
  • Patent litigation and damages

Why you should attend

The area of US patent practice can be complex and confusing. Are you up to date with the latest court decisions and best practice?

This highly interactive seminar will give you a comprehensive understanding of the US patent system and enable you to work more effectively with your US counterparts. It will highlight the important differences between US and European patent practice and provide you with the opportunity for in-depth discussions about prosecution practice and procedure throughout the two days. The programme will cover important tactics to get the most out of your prosecution dollar, and provide lots of claim drafting tips to give your application a solid footing for US prosecution and enforcement.

This event will bring you right up to date on the latest legislative changes under the America Invents Act (AIA), as well as all the recent and pending US Supreme and other court decisions of importance. You will also get to grips with current happenings in the USPTO that could impact on your role.

This is a fantastic opportunity to take full advantage of the open seminar environment that this event offers. With a high degree of interaction with the expert trainers as well as other participants, this is a great forum for discussing your particular questions and concerns. Offering a wide-ranging and detailed understanding, this seminar covers what every European patent practitioner should know about US patent practice.

Who should attend?

  • Corporate patent counsel
  • Patent attorneys from corporate and private practice
  • Intellectual property consultants
  • Patent managers and engineers
  • Company legal advisers
  • All those involved with patent protection in the United States

Accreditation

This seminar merits 12.5 hours under the UK Solicitors Regulatory Authority self accreditation scheme (refg. CJA/MAFO) and may also be relevant training under the IPREG CPD self accreditation scheme.

Enrol now

The US Patent Practice course will cover:

Legal framework

  • Statutes and rules
  • Courts and agencies
  • Requirements for patentability

Claim construction

  • Phillips – broad multifaceted inquiry
  • Claim construction rules and guidelines
  • Claim construction in the USPTO

US patent prosecution – general flow of events

Written description

  • ‘Possession’ of claimed invention
  • Ariad – increased focus on what inventors actually did
  • Written description guidelines
  • Negative limitations

Enablement

  • Wands factors – to show whether the amount of experimentation necessary would be ‘undue’
  • Interplay with written description requirement

Best mode

  • Effect of the AIA

Definiteness

  • Nautilus – the ‘reasonable certainty’ standard
  • USPTO practice

Means-plus-function claiming

Statutory subject matter

  • Supreme Court jurisprudence
  • USPTO guidance
  • Court of Appeal

Utility

  • Impossibility
  • Judicial interpretation

Patent Law Treaty implementation

Novelty and prior art

  • Anticipation
  • Pre-AIA – ‘first to invent’
  • Post-AIA – ‘first to file’

Obviousness

  • Graham and KSR
  • USPTO practice – prima facie obviousness
  • USPTO KSR guidelines
  • Method claims

Provisional applications

  • Pre-AIA vs post-AIA

Continuing applications

  • Continuations, divisionals, continuations-in-part

Restriction practice

  • Restriction requirement
  • Restriction vs Election of Species
  • Rejoinder

Patent term and PTA

Obviousness – type double patenting

  • Gilead cases
  • Terminal disclaimers

USPTO programs

  • Terminal disclaimers

Patent Law Treaty implementation

Obviousness – type double patenting (continued)

  • Accelerated examination, track one, patent prosecution highway
  • First action interview, after-final consideration, pre-appeal brief request for review pilot programs

Duty of candor

  • Citation of references
  • Inequitable conduct

Inventorship

  • Conception
  • Joint inventorship
  • Interference practice
  • Derivation actions

Post-issuance practice

  • Re-examination and re-issue
  • Inter partes review
  • Post-grant review
  • Covered business method review
  • Supplemental examination
  • Certificates of correction

Infringement

  • Direct infringement
  • Contributory infringement and inducement
  • Extraterritorial infringement
  • Exhaustion

Doctrine of equivalents

  • Function/way/result test
  • Festo – prosecution history estoppel
  • Licensing

Willfulness

  • Opinions

Declaratory judgment

  • Burdens of proof

Patent litigation and damages

  • Remedies
  • Entire market value
  • Injunctive relief

Enrol now

James Suggs

James V. Suggs is a partner in the intellectual property law firm McDonnell Boehnen Hulbert & Berghoff LLP, located in Chicago, where he practices patent law and serves as Chair of the firm’s Chemical Practice Group. He applies his broad technical experience in a wide variety of chemical, polymer, materials science, pharmaceutical, optical, photonic, semiconductor and related technologies. He handles all facets of patent law, with an especial focus in patent procurement, strategic counseling, freedom-to-operate and due diligence opinions.

He also has an active inter partes review practice. His litigation experience includes federal district court and appellate practice as well as advocacy in forums such as the International Trade Commission, and spans a diverse range of technologies. He has experience with all kinds of clients, from large multinational corporations, to science-based startups, to academic research institutions, and works with law firms in Europe and worldwide to successfully prosecute their applications at the USPTO.

More details

Nicole Reifman

Nicole Reifman is a partner with McDonnell Boehnen Hulbert & Berghoff LLP, Chicago where she has gained diverse experience in obtaining, evaluating and enforcing intellectual property. She has experience in all phases of patent preparation and prosecution, and concentrates in representing clients in the mechanical and electrical arts, including drive train systems, medical devices, electromechanical, telecommunications and material sciences matters. She also has experience in all phases of patent litigation.

She provides counselling regarding the procurement, enforcement, and licensing of intellectual property rights, including trademark, trade secret and copyright issues. She actively manages trademark portfolios and develops brand building and protection strategies for her clients. She is also the Recent Developments Editor of the University of Illinois Journal of Law, Technology, and Policy.

More details

Book US Patent Practice Live online/Classroom training

1-2 Dec 2021

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 11103

  • GBP 899 1,099
  • EUR 1,299 1,579
  • USD 1,474 1,786

Until 27 Oct

In your basket 

1-2 Mar 2022

Classroom
London venue TBC

09:00-17:00 UK (London)
Course code 11453

  • GBP 1,099 1,299
  • EUR 1,539 1,819
  • USD 1,714 2,026

Until 25 Jan

  • 2 days classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy

In your basket 

8-9 Jun 2022

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 11648

  • GBP 899 1,099
  • EUR 1,299 1,579
  • USD 1,474 1,786

Until 04 May

In your basket 

15-16 Dec 2022

Live online

09:00-17:00 UK (London) (UTC+00)
10:00-18:00 Paris (UTC+01)
04:00-12:00 New York (UTC-05)
Course code 11786

  • GBP 899 1,099
  • EUR 1,299 1,579
  • USD 1,474 1,786

Until 10 Nov

In your basket 

Reviews of IPI's US Patent Practice training course


Excellent! Very good and helpful overview of US patent law with a focus on the differences to European law. I particularly liked the very interactive discussions.

Dec 5 2019

Hendrik Freudenberger
IP Legal Advisor, Sasol Chemie GmbH & Co. KG

Dec 5 2019

Very thorough and well presented.

Elisabetta Mauri
Director of Intellectual Property, Dompé Farmaceutici SPA

Dec 5 2019

The course gives European practitioners a good overview of the peculiarities of US patent law and the ways in which US practice sometimes differs from our own. The presentation was lively and the speakers provided plenty of background from their own experience.

Erik Bartelds
patent attorney, Arnold + Siedsma

Dec 4 2018

Excellent speakers.

Omar Jabarti
Engineer, Saudi Aramco

Jun 13 2018

A great overview, excellent speakers with comprehensive knowledge.

Peter Atzmüller
Key Patent Information Professional, voestalpine Stahl GmbH

Jun 13 2018

The course was exactly what I expected with a good quality of written documentation and highlighting of specific ongoing topics by the speakers.

Andreas Bazzon
Patent Attorney Candidate, Kaminski Harmann Patentanwälte AG

Jun 13 2018

Both entertaining and educative.

Lorenz Kallenbach
Corporate Patent Counsel, Merck

Jun 13 2018

The dual presentation works well. Interaction with audience very positive. Comprehensive update on US patent practice by knowledgeable speakers in an interactive atmosphere.

Marijke Hogenbirk
Senior Patent Attorney , Shell International B.V.

Jun 13 2018

The speakers were very direct and the course was interactive – I never for a minute lost interest.

Asteria Zitrou
Intellectual Property Supervisor, Pharmathen

Jun 14 2017

The course gave a very good general picture of US patent practice and I really liked all the real-life examples.

Leena Marquis
Patent Engineer, Seppo Laine Oy

Jun 14 2017

Tphe resenter was engaging and open to questions.

Claire Goodier
Director of Intellectual Property, International, The Boots Company plc

Dec 5 2016

The speakers are excellent.

Paul Van Helvert
Manager Intellectual Property, Wageningen UR

Dec 5 2016

Entertaining and interesting programme.

Patrick John Couzens
Patent Attorney, Société des Produits Nestlé S.A.

UK

  • AA Thornton & Co
  • Albany International Ltd
  • ARM Holdings plc
  • AstraZeneca PLC
  • AstraZeneca R&D Charnwood
  • BOC Limited
  • Boult Wade Tennant
  • BP International Ltd
  • BT Group Legal
  • Cambridge Display Technology Ltd
  • Croda Europe Limited
  • D Young & Co LLP
  • Danfoss
  • David H L Edwards Ltd
  • De La Rue International Ltd
  • Dechert LLP
  • DePuy International Limited
  • Dupont Teijin Films UK Ltd
  • EBS DEALING RESOURCES INT LTD
  • Element Six Ltd
  • Eli Lilly & Co Ltd
  • GE Healthcare UK Ltd
  • Glory Global Solutions
  • Hoffmann Eitle
  • Hoffmann Eitle & Partner
  • Infineum UK Ltd
  • ip21 Limited
  • Kennedys Patent
  • Lifescan Scotland Ltd
  • Mewburn Ellis LLP
  • Nissan Technical Centre Europe
  • Nokia UK Ltd
  • NXP Semicondutors
  • Olswang LLP
  • ORANGE Ltd
  • Oxford Gene Technology IP Ltd
  • Pfizer Limited
  • Procter & Gamble Technical Centres Limited
  • Procter & Gamble Technical Centres Ltd
  • QinetiQ Limited
  • R G C Jenkins & Co
  • Rolls Royce PLC
  • Schlumberger Cambridge Research
  • Sharp Laboratories of Europe Limited
  • Sharp Life Science (EU) Limited
  • Solexa
  • Sony Europe Limited
  • Stratagem IPM Limited
  • Syngenta Limited
  • Teva UK Ltd
  • The Boots Company plc
  • u-blox Melbourn Ltd
  • Unilever PLC
  • Vectura Group plc
  • Warwick Partnership Ltd
  • Williams Powell
  • Wolfson Microelectronics PLC
  • Xeros Limited

Netherlands

  • AOMB Intellectual Property Consultants
  • Arnold & Siedsma
  • Arnold + Siedsma
  • ASML Netherlands BV
  • Draka Comteq Fibre BV
  • DSM IP & Licensing BV
  • EDP Patent Attorneys B.V.
  • EP&C
  • Helze BV
  • Liquavista BV
  • NLO
  • Nutricia Research BV
  • Octrooibureau Van der Lely N.V.
  • Philips International B.V. - IP&S
  • Shell International B.V.
  • Shell International BV
  • TBG Europe NV
  • TomTom International B.V.
  • Unilever Patent Group
  • Unitpat B.V.
  • V.O.
  • Wageningen UR

Denmark

  • Alk Abello
  • Ambu A/S
  • Awapatent A/S
  • Budde Schou
  • Chas Hude A/S
  • Coloplast A/S
  • Dako Denmark A/S
  • DuPont Nutrition Biosciences ApS
  • Ferring Pharmaceuticals
  • Fertin Pharma A/S
  • Genmab A/S
  • Glycom A/S
  • Hoiberg A/S
  • Høiberg P/S
  • Leo Pharma A/S
  • Nokia Danmark A/S
  • Novo Nordisk A/S
  • Patentgruppen A/S
  • Santaris Pharma
  • Widex A/S

Germany

  • AiCuris Anti-infective Cures AG
  • ALBIHNS GmbH
  • Bardehle Pagenberg Partnerschaft mbB
  • DEGUSSA AG
  • European Patent Office
  • GPC BIOTECH AG
  • Grunenthal GmbH
  • Hafner and Partner
  • Henkel KGaA
  • OSRAM Opto Semiconductors GmbH
  • Procter & Gamble Service GmbH
  • Sasol Chemie GmbH & Co. KG
  • Umicore AG & Co. KG
  • Volkswagen AG
  • White & Case LLP

Switzerland

  • Actelion Pharmaceutical Ltd
  • Alstom Technology Ltd
  • Bemido SA
  • F. Hoffmann-La Roche AG
  • F. Hoffmann-La Roche Ltd
  • Geistlich Pharma AG
  • INVENTO AG
  • Merck
  • Nestec SA
  • Novartis Pharma AG
  • Procter & Gamble
  • Roche Diagnostics Ltd
  • Schneider Feldmann AG
  • SERONO INTERNATIONAL SA
  • Société des Produits Nestlé S.A.

Sweden

  • AB Electrolux
  • Alfa Laval Corporate AB
  • Aros Patent AB
  • Brann AB
  • Ericsson AB
  • Ericsson AB (EAB)
  • ESAB AB
  • Hansson Thyresson Patentbyra AB
  • Östlund Patent AB
  • Sony Mobile Communications AB
  • Spotify
  • Spotify AB
  • Valea AB
  • Zacco Sweden AB

Belgium

  • Beloem
  • CNH Industrial Belgium NV
  • De Clercq & Partners
  • ExxonMobil Chemical Europe Inc
  • Fujirebio-Europe NV
  • IMEC vzw
  • Janssen Pharmaceutica NV
  • P&G
  • Sofics BVBA
  • Umicore Research & Development
  • Yara SA/NV

Italy

  • Alfa Wassermann S.p.A.
  • Barzano&Zanardo Roma spa
  • Dompé Farmaceutici SPA
  • Invatec SRL
  • Pirelli & C SPA
  • Provvisionato & Co S.r.l.
  • Sealed Air S.r.l.
  • Sisvel SpA
  • Solvay Solexis SpA
  • Studio Bonini Srl

Finland

  • Berggren Oy Ab
  • Kemira OYJ
  • Kolster OY AB
  • Microsoft Mobile Oy
  • Primrose Oy
  • Seppo Laine Oy
  • Tampereen Patenttitoimisto Oy
  • UPM-Kymmene Corporation
  • VTT (Technical Research Centre of Finland)

Spain

  • Corporación Medichem, S.L.
  • J Uriach Y Compania
  • KAO Corporation S.A.
  • Oficini Ponti, S.L.
  • Uriach
  • ZBM Patents S.L.

Austria

  • Borealis Polyolefine GmbH
  • Sandoz GmbH
  • Sonn & Partner
  • Valneva Austria GmbH
  • voestalpine Stahl GmbH

France

  • Cabinet Barre Laforgue & Associes
  • Cabinet Michel Richebourg
  • Cabinet NONY
  • Chanel PB
  • SEB Developpement

Poland

  • EUPATENT.PL Adam Pawlowski
  • PATPOL
  • Patpol Kancelaria Patentowa sp. z o.o.
  • Patpol Kancelaria Patentowa sp. z.o.o.

Liechtenstein

  • Kaminski Harmann Patentanwalte
  • Kaminski Harmann Patentanwälte AG
  • Kaminski Harmann Patentwalte

Portugal

  • Industrial Property Portuguese Office
  • J E Dias Costa, Lda
  • Raul Cesar Ferreira (Herd) SA

Hungary

  • Chinoin Zrt - member of sanofi-aventis Group
  • EGIS Pharmaceuticals PLC

Saudi Arabia

  • Al-Elm Information Security
  • Saudi Aramco

Singapore

  • China Sinda Intellectual Property Pte Ltd
  • Panasonic Singapore Laboratories

United States of America

  • Microsoft Mobile Oy
  • Scynexis Inc

Canada

  • Novelis Inc

Greece

  • Pharmathen

Hong Kong

  • ASTEC CUSTOM POWER (HK) LTD

India

  • GE India Technology Centre Pvt Ltd

Norway

  • StatoilHydro ASA

Russia

  • Technology Company Schlumberger

Slovenia

  • LEK Pharmaceuticals d.d.

Turkey

  • Sanovel Pharmaceutical INC

Enrol now

Multiple colleagues?
Talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra BEER
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy